(Q44494074)

3 December 2017

title

DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians (English)

1 reference

3 December 2017

0 references

Caballero A

1

1 reference

3 December 2017

Alvés-León S

2

1 reference

3 December 2017

Papais-Alvarenga R

3

1 reference

3 December 2017

Fernández O

4

1 reference

3 December 2017

Navarro G

5

1 reference

3 December 2017

Alonso A

6

1 reference

3 December 2017

publication date

1 November 1999

1 reference

3 December 2017

1 reference

3 December 2017

volume

54

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

524-526

1 reference

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

Multiple sclerosis in Arabs in Jordan

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

HLA associations with multiple sclerosis in the Canary Islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

HLA and disease associations: detecting the strongest association

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

MS epidemiology world wide. One view of current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

7 January 2021

Extended major histocompatibility complex haplotypes in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

7 January 2021

Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type)

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

7 January 2021

Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

7 January 2021

The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.1999.540511.X

7 January 2021

10.1034/J.1399-0039.1999.540511.X

Identifiers

DOI

1 reference

3 December 2017

1 reference